Monoclonal antibody T101-Y-90 conjugate

Drug Profile

Monoclonal antibody T101-Y-90 conjugate

Alternative Names: 90Y-T101

Latest Information Update: 22 Aug 2002

Price : $50

At a glance

  • Originator Hybritech; Nonindustrial source
  • Class Antineoplastics; Monoclonal antibodies
  • Mechanism of Action Immunosuppressants; Ionising radiation emitters
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Haematological malignancies

Most Recent Events

  • 17 Dec 1998 New profile
  • 17 Dec 1998 Phase-I clinical trials for Haematological malignancies in USA (Injection)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top